Bioequivalence Study of Vonoprazan From Topoprazan 20 mg Tablets (Hikma Pharma, Egypt) Versus Takecab 20 mg Tablets (Takeda Pharmaceutical Co. Ltd., Japan)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 19, 2021

Primary Completion Date

February 2, 2021

Study Completion Date

March 1, 2021

Conditions

Healthy

Interventions

DRUG

Topoprazan

1 tablet contains 20 mg vonoprazan

DRUG

Takecab

1 tablet contains 20 mg vonoprazan

Trial Locations (1)

Genuine Research Center GRC, Cairo